InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Stoke Therapeutics, Inc.

STOK Clue Score65
United States Fiscal year ends December CIK 0001623526 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

91
Insider
Date
Role
Action
Shares
Price
Amount
Barry Ticho
19 Mar 2026
Chief Medical Officer
Sold after exercise
1,461
$29.99
$43.82K
Arthur Tzianabos
10 Mar 2026
Interim Executive Chair
Sold after exercise
4,355
$40.00
$174.21K
Edward M. MD Kaye
8 Oct 2025
Director
Sold after exercise
25,000
$30.00
$750.00K
Jonathan Allan
3 Oct 2025
General Counsel & Corp Sec
Sold after exercise
10,000
$25.07
$250.65K
Jonathan Allan
2 Sep 2025
General Counsel & Corp Sec
Sold after exercise
14,922
$20.14
$300.49K
Jonathan Allan
29 Aug 2025
General Counsel & Corp Sec
Sold after exercise
850
$20.00
$17.00K
Barry Ticho
2 Dec 2024
Chief Medical Officer
Sold after exercise
10,000
$12.07
$120.70K
Barry Ticho
1 Nov 2024
Chief Medical Officer
Sold after exercise
10,000
$12.68
$126.80K
Barry Ticho
1 Oct 2024
Chief Medical Officer
Sold after exercise
10,000
$12.06
$120.65K
Barry Ticho
3 Sep 2024
Chief Medical Officer
Sold after exercise
600
$15.41
$9.24K
Barry Ticho
3 Sep 2024
Chief Medical Officer
Sold after exercise
9,400
$14.92
$140.24K
Barry Ticho
1 Aug 2024
Chief Medical Officer
Sold after exercise
10,000
$14.58
$145.84K
Barry Ticho
1 Jul 2024
Chief Medical Officer
Sold after exercise
10,000
$13.75
$137.46K
Barry Ticho
3 Jun 2024
Chief Medical Officer
Sold after exercise
103
$15.78
$1.63K
Barry Ticho
3 Jun 2024
Chief Medical Officer
Sold after exercise
9,897
$15.21
$150.56K
Jonathan Allan
20 May 2024
General Counsel & Corp Sec
Sold after exercise
8,599
$15.04
$129.33K
Huw M. Nash
20 May 2024
COO & Cbo
Sold after exercise
50,000
$15.39
$769.50K
Barry Ticho
1 May 2024
Chief Medical Officer
Sold after exercise
10,000
$11.37
$113.65K
Huw M. Nash
1 Apr 2024
COO & Cbo
Sold after exercise
400
$13.61
$5.44K
Huw M. Nash
1 Apr 2024
COO & Cbo
Sold after exercise
60,929
$13.22
$805.77K
Barry Ticho
1 Apr 2024
Chief Medical Officer
Sold after exercise
9,426
$13.23
$124.68K
Barry Ticho
1 Mar 2024
Chief Medical Officer
Sold after exercise
10,000
$7.75
$77.47K
Huw M. Nash
3 Jan 2022
COO & Cbo
Sold after exercise
200
$24.07
$4.81K
Huw M. Nash
3 Jan 2022
COO & Cbo
Sold after exercise
2,103
$23.40
$49.22K
Huw M. Nash
3 Jan 2022
COO & Cbo
Sold after exercise
1,497
$22.47
$33.63K
Huw M. Nash
1 Dec 2021
COO & Cbo
Sold after exercise
2,500
$25.06
$62.66K
Huw M. Nash
1 Dec 2021
COO & Cbo
Sold after exercise
3,200
$23.96
$76.67K
Huw M. Nash
3 Nov 2021
COO & Cbo
Sold after exercise
1,900
$25.00
$47.50K
Huw M. Nash
1 Nov 2021
COO & Cbo
Sold after exercise
1,610
$23.72
$38.20K
Huw M. Nash
1 Nov 2021
COO & Cbo
Sold after exercise
2,190
$23.41
$51.26K
Huw M. Nash
1 Oct 2021
COO & Cbo
Sold after exercise
5,700
$24.83
$141.51K
Huw M. Nash
1 Sep 2021
COO & Cbo
Sold after exercise
5,700
$26.00
$148.22K
Huw M. Nash
2 Aug 2021
COO & Cbo
Sold after exercise
5,700
$28.87
$164.55K
Huw M. Nash
1 Jul 2021
COO & Cbo
Sold after exercise
5,700
$33.33
$189.99K
Huw M. Nash
1 Jun 2021
COO & Cbo
Sold after exercise
575
$39.43
$22.67K
Gene Liau
2 Mar 2021
EVP Research & Preclinical Dev
Sold after exercise
2,900
$63.52
$184.19K
Gene Liau
2 Mar 2021
EVP Research & Preclinical Dev
Sold after exercise
2,295
$62.46
$143.35K
Arthur A Levin
1 Mar 2021
Director
Sold after exercise
4,957
$61.14
$303.09K
Arthur A Levin
1 Mar 2021
Director
Sold after exercise
7,543
$60.55
$456.75K
Stephen J Tulipano
23 Feb 2021
CFO
Sold after exercise
5,000
$58.60
$292.99K
Stephen J Tulipano
22 Feb 2021
CFO
Sold after exercise
102
$60.00
$6.12K
Stephen J Tulipano
22 Feb 2021
CFO
Sold after exercise
9,696
$59.29
$574.84K
Stephen J Tulipano
22 Feb 2021
CFO
Sold after exercise
15,202
$58.67
$891.94K
Arthur Tzianabos
19 Feb 2021
Director
Sold after exercise
10,000
$60.67
$606.65K
Huw M. Nash
4 Jan 2021
COO & Cbo
Sold after exercise
200
$60.51
$12.10K
Huw M. Nash
4 Jan 2021
COO & Cbo
Sold after exercise
1,800
$59.85
$107.72K
Huw M. Nash
4 Jan 2021
COO & Cbo
Sold after exercise
2,200
$59.02
$129.84K
Huw M. Nash
4 Jan 2021
COO & Cbo
Sold after exercise
1,500
$57.66
$86.49K
Gene Liau
28 Dec 2020
EVP Research & Preclinical Dev
Sold after exercise
149
$58.73
$8.75K
Barry Ticho
21 Dec 2020
Chief Medical Officer
Sold after exercise
365
$59.00
$21.53K
Barry Ticho
21 Dec 2020
Chief Medical Officer
Sold after exercise
286
$58.02
$16.59K
Barry Ticho
21 Dec 2020
Chief Medical Officer
Sold after exercise
714
$56.76
$40.53K
Huw M. Nash
18 Dec 2020
COO & Cbo
Sold after exercise
8,015
$60.00
$480.90K
Huw M. Nash
17 Dec 2020
COO & Cbo
Sold after exercise
41,985
$60.00
$2.52M
Huw M. Nash
1 Dec 2020
COO & Cbo
Sold after exercise
400
$52.72
$21.09K
Huw M. Nash
1 Dec 2020
COO & Cbo
Sold after exercise
100
$51.45
$5.15K
Huw M. Nash
1 Dec 2020
COO & Cbo
Sold after exercise
2,481
$50.02
$124.10K
Huw M. Nash
1 Dec 2020
COO & Cbo
Sold after exercise
2,719
$49.19
$133.74K
Arthur Tzianabos
23 Nov 2020
Director
Sold after exercise
210
$47.61
$10.00K
Arthur Tzianabos
23 Nov 2020
Director
Sold after exercise
5,294
$46.85
$248.01K
Arthur Tzianabos
23 Nov 2020
Director
Sold after exercise
10,196
$45.97
$468.72K
Arthur Tzianabos
23 Nov 2020
Director
Sold after exercise
4,300
$45.08
$193.84K
Huw M. Nash
10 Nov 2020
COO & Cbo
Sold after exercise
50,000
$45.00
$2.25M
Stephen J Tulipano
4 Nov 2020
CFO
Sold after exercise
5,216
$41.97
$218.91K
Stephen J Tulipano
4 Nov 2020
CFO
Sold after exercise
11,111
$41.42
$460.21K
Stephen J Tulipano
4 Nov 2020
CFO
Sold after exercise
16,941
$40.03
$678.09K
Stephen J Tulipano
3 Nov 2020
CFO
Sold after exercise
1,732
$39.84
$69.00K
Huw M. Nash
2 Nov 2020
COO & Cbo
Sold after exercise
2,536
$37.98
$96.32K
Huw M. Nash
2 Nov 2020
COO & Cbo
Sold after exercise
3,164
$36.59
$115.78K
Stephen J Tulipano
2 Nov 2020
CFO
Sold after exercise
400
$38.44
$15.37K
Stephen J Tulipano
2 Nov 2020
CFO
Sold after exercise
14,445
$37.86
$546.91K
Stephen J Tulipano
2 Nov 2020
CFO
Sold after exercise
20,155
$36.79
$741.45K
Gene Liau
19 Oct 2020
EVP Research & Preclinical Dev
Sold after exercise
7,225
$38.42
$277.59K
Gene Liau
19 Oct 2020
EVP Research & Preclinical Dev
Sold after exercise
24,775
$37.64
$932.58K
Gene Liau
16 Oct 2020
EVP Research & Preclinical Dev
Sold after exercise
5,851
$40.00
$234.04K
Gene Liau
13 Oct 2020
EVP Research & Preclinical Dev
Sold after exercise
1,649
$40.00
$65.96K
Huw M. Nash
1 Oct 2020
COO & Cbo
Sold after exercise
2,300
$34.86
$80.18K
Huw M. Nash
1 Oct 2020
COO & Cbo
Sold after exercise
3,400
$34.33
$116.72K
Huw M. Nash
9 Sep 2020
COO & Cbo
Sold after exercise
17,201
$30.00
$516.03K
Huw M. Nash
8 Sep 2020
COO & Cbo
Sold after exercise
30,718
$30.00
$921.54K
Huw M. Nash
1 Sep 2020
COO & Cbo
Sold after exercise
700
$28.71
$20.10K
Huw M. Nash
1 Sep 2020
COO & Cbo
Sold after exercise
5,000
$27.60
$138.02K
Huw M. Nash
28 Aug 2020
COO & Cbo
Sold after exercise
2,081
$30.00
$62.43K
Huw M. Nash
3 Aug 2020
COO & Cbo
Sold after exercise
5,700
$24.73
$140.94K
Huw M. Nash
16 Jul 2020
COO & Cbo
Sold after exercise
1,900
$25.06
$47.61K
Huw M. Nash
1 Jul 2020
COO & Cbo
Sold after exercise
3,800
$23.15
$87.97K
Huw M. Nash
1 Jun 2020
COO & Cbo
Sold after exercise
500
$27.48
$13.74K
Huw M. Nash
1 Jun 2020
COO & Cbo
Sold after exercise
1,607
$27.08
$43.52K
Gene Liau
1 Jun 2020
EVP Research & Preclinical Dev
Sold after exercise
1,230
$27.48
$33.80K
Gene Liau
1 Jun 2020
EVP Research & Preclinical Dev
Sold after exercise
7,875
$26.91
$211.92K
Gene Liau
1 Jun 2020
EVP Research & Preclinical Dev
Sold after exercise
10,895
$25.82
$281.31K
Showing 250 of 267 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 276
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 75
Sales straight out of an exercise 96
Sales at will 77
Transactions with no price 0
Shares from compensation/vesting 53,171,597
Sales filed before the plan box existed 15
History held since 20 Jun 2019